Nephros Inc. Director Awarded Routine Stock Grant
NEPHROS INC
Subscribe to track NEPH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Nephros Director Receives Stock Grant
Company: Nephros Inc. (NEPH) Form: 4 | Filed: 2025/11/13 Significance: Low
Insider: Nettis Lisa Marie Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 1,622 • Price: $0.00 • Value: $0 • Owned After: 1,622
Key Insight: A director received a routine stock award of 1,622 shares, representing a negligible 0.015% of shares outstanding.
Market Context: This is a common form of non-cash compensation for board members in a small-cap company and does not reflect a market sentiment transaction.
Comprehensive Analysis
SEC Filing Analysis: NEPHROS INC (NEPH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine, non-cash stock award as part of their compensation, with negligible impact on the company's share structure.
- Market Impact: Neutral. This is a standard corporate action, not an open-market transaction reflecting insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | NEPHROS INC |
| Ticker Symbol | NEPH |
| CIK | 0001196298 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Nettis Lisa Marie |
| CIK | 0002076008 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-10 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 1,622 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 1,622 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 1,622 |
| % of Shares Outstanding | 0.015% |
| Post-Transaction Ownership | 1,622 shares (0.015% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has a $0 value and is immaterial against the company's $50 million market capitalization.
- Ownership Concentration: The director's direct holdings in common stock are initiated with this grant, representing a minimal 0.015% of total shares outstanding.
- Dilution Impact: The grant introduces 1,622 new shares, causing a negligible dilution of 0.015% to existing shareholders.
- Transaction Significance: The transaction is a routine grant, common for director compensation, and holds low significance due to its zero dollar value and minimal impact on the share count.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a pre-planned compensation award, not an open-market transaction. It does not signal a change in the insider's view of the company's valuation.
Volume & Sentiment
- Expected Volume Impact: None. The transaction did not occur on the open market.
- Sentiment Indicator: Neutral. The filing is informational regarding director compensation.
Key Takeaways
- Director Lisa Marie Nettis was granted 1,622 shares of common stock at no cost.
- This transaction is a form of non-cash compensation and not an investment decision based on market conditions.
- The impact on share dilution and the director's total ownership is negligible.
Additional Context
Transaction Notes
- The filing also discloses a separate holding of 13,229 stock options with a strike price of $4.49, which are not part of this specific transaction.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.